Mass Spectrometry and Cancers

Dear Colleagues,

Over the past two decades, mass spectrometry technology has contributed to a wide range of biomolecular disciplines directed toward the study of RNA species (transcriptomics), proteins (proteomics), lipids (lipidomics), glycans (glycomics), metabolites (metabolomics), and oligonucleotides. The spread of these disciplines has been possible mainly through the development of novel and high-throughput mass spectrometry technologies and informatics tools capable of generating large amounts of data related to different levels of biological complexity (DNA, mRNA, proteins, metabolites, etc.). Emerging mass spectrometry technologies are likely to influence the development of omics-based analysis of cancer in the future, as both types and numbers of molecular measurements continue to increase. Furthermore, the combination of different approaches generates more comprehensive information, ultimately leading to a deeper understanding of cancer. There is a strong interest in pushing mass spectrometry technologies in the direction of highly personalized medicine to achieve targeted therapies capable of halting tumor progression. The purpose of this Special Issue is to outline the recent advances of mass spectrometry application in cancer that are contributing to biomarker discovery for early diagnosis, prognosis, and appropriate therapeutics.

Dr. Rita Casadonte
Dr. Kristina Schwamborn
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.